{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:59:20Z","timestamp":1776113960563,"version":"3.50.1"},"reference-count":105,"publisher":"Microbiology Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:p>The majority of infections initiate their departure from a mucosal surface, such as<jats:italic>Human immunodeficiency virus<\/jats:italic>(HIV), a sexually transmitted virus. Therefore, the induction of mucosal immunity is a high priority in the development of vaccines against mucosal pathogens. The selection of an appropriate antigen delivery system is necessary to induce an efficient mucosal immune response. Poxvirus vectors have been the most intensively studied live recombinant vector, and numerous studies have demonstrated their ability to induce mucosal immune responses against foreign expressed antigens. Previous studies have demonstrated that recombinants based on the attenuated modified vaccinia virus Ankara (MVA) vector were effective in inducing protective responses against different respiratory viruses, such as influenza and respiratory syncytial virus, following immunization via mucosal routes. Recent studies performed in the murine and macaque models have shown that recombinant MVA (rMVA) does not only stimulate HIV-specific immunity in the genital and rectal tracts following mucosal delivery, but can also control simian\/human immunodeficiency viraemia and disease progression. In addition, a prime-boost vaccination approach against tuberculosis emphasized the importance of the intranasal rMVA antigen delivery to induce protective immunity against<jats:italic>Mycobacterium tuberculosis<\/jats:italic>. The aim of this review is to summarize the studies employing recombinant poxviruses, specifically rMVA as a mucosal delivery vector. The results demonstrate that rMVAs can activate specific immune responses at mucosal surfaces, and encourage further studies to characterize and improve the MVA mucosal immunogenicity of poxvirus vectors.<\/jats:p>","DOI":"10.1099\/vir.0.81181-0","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T04:12:50Z","timestamp":1129263170000},"page":"2925-2936","source":"Crossref","is-referenced-by-count":60,"title":["Recombinant poxviruses as mucosal vaccine vectors"],"prefix":"10.1099","volume":"86","author":[{"given":"M. Magdalena","family":"Gherardi","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology, Centro Nacional de Biotecnolog\u00eda, CSIC, Ciudad Universitaria Cantoblanco, 28049 Madrid, Spain"},{"name":"National Reference Center for AIDS, Department of Microbiology, School of Medicine, University of Buenos Aires, Paraguay 2155 piso 11 (C1121ABG), Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Centro Nacional de Biotecnolog\u00eda, CSIC, Ciudad Universitaria Cantoblanco, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"key":"R2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1073\/pnas.95.4.1709","article-title":"Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge","volume":"95","author":"Belyakov","year":"1998a","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.72.10.8264-8272.1998","article-title":"Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein","volume":"72","author":"Belyakov","year":"1998b","journal-title":"J Virol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.96.8.4512","article-title":"Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity","volume":"96","author":"Belyakov","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.70.9.6418-6424.1996","article-title":"Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza","volume":"70","author":"Bender","year":"1996","journal-title":"J Virol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/IAI.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect Immun"},{"key":"R7","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.172.6.3745","article-title":"Control of simian\/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates","volume":"172","author":"Bertley","year":"2004","journal-title":"J Immunol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"R10","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1128\/JVI.72.12.9567-9574.1998","article-title":"Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity","volume":"72","author":"Blaney","year":"1998","journal-title":"J Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J Exp Med"},{"key":"R12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1099\/vir.0.18942-0","article-title":"Vaccinia virus transcription","volume":"84","author":"Broyles","year":"2003","journal-title":"J Gen Virol"},{"key":"R13","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/JVI.71.4.3031-3038.1997","article-title":"Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector","volume":"71","author":"Caley","year":"1997","journal-title":"J Virol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"R15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0264-410X(00)00481-3","article-title":"Vaccines and mucosal immunisation","volume":"19","author":"Cripps","year":"2001","journal-title":"Vaccine"},{"key":"R16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?","volume":"15","author":"Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0264-410X(98)00010-3","article-title":"The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys","volume":"16","author":"Durbin","year":"1998","journal-title":"Vaccine"},{"key":"R18","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.4049\/jimmunol.166.9.5473","article-title":"Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules","volume":"166","author":"Eo","year":"2001","journal-title":"J Immunol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0952-7915(02)00384-9","article-title":"Recent advances in mucosal vaccines and adjuvants","volume":"14","author":"Eriksson","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"R20","first-page":"2885","article-title":"Poxviruses","volume-title":"In Fields Virology","author":"Esposito","year":"2001"},{"key":"R21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/14.1.31","article-title":"Prime-boost immunization generates a high frequency, high-avidity CD8+ cytotoxic T lymphocyte population","volume":"14","author":"Estcourt","year":"2002","journal-title":"Int Immunol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/JVI.77.4.2400-2409.2003","article-title":"Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system","volume":"77","author":"Evans","year":"2003","journal-title":"J Virol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/314445","article-title":"Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract","volume":"178","author":"Ferko","year":"1998","journal-title":"J Infect Dis"},{"key":"R24","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.75.19.8899-8908.2001","article-title":"Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice","volume":"75","author":"Ferko","year":"2001","journal-title":"J Virol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1128\/JVI.77.19.10606-10622.2003","article-title":"Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells","volume":"77","author":"Gallego-Gomez","year":"2003","journal-title":"J Virol"},{"key":"R26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0264-410X(98)00324-7","article-title":"Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants","volume":"17","author":"Gherardi","year":"1999","journal-title":"Vaccine"},{"key":"R27","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.4049\/jimmunol.162.11.6724","article-title":"IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner","volume":"162","author":"Gherardi","year":"1999","journal-title":"J Immunol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1128\/JVI.74.14.6278-6286.2000","article-title":"Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime\/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide","volume":"74","author":"Gherardi","year":"2000","journal-title":"J Virol"},{"key":"R29","first-page":"655","article-title":"Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens","volume":"16","author":"Gherardi","year":"2001","journal-title":"Histol Histopathol"},{"key":"R30","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1128\/JVI.77.12.7048-7057.2003","article-title":"Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes","volume":"77","author":"Gherardi","year":"2003","journal-title":"J Virol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule","volume":"172","author":"Gherardi","year":"2004","journal-title":"J Immunol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1073\/pnas.88.18.8011","article-title":"A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions","volume":"88","author":"Giavedoni","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33","first-page":"178","article-title":"Adenoviruses as vectors for HIV vaccines","volume":"5","author":"Gomez-Roman","year":"2003","journal-title":"AIDS Rev"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"R35","first-page":"p","article-title":"Priming with a candidate HIV-1 clade A DNA vaccine followed by booster with HIV-1 clade A MVA vaccine in volunteers at low risk of infection","volume":"04","author":"Guimaraes-Walker","year":"2004","journal-title":"AIDS Vaccine"},{"key":"R36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/79626","article-title":"Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya","volume":"6","author":"Hanke","year":"2000","journal-title":"Nat Med"},{"key":"R37","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2004.08.050","article-title":"Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice","volume":"23","author":"Hanke","year":"2005","journal-title":"Vaccine"},{"key":"R38","first-page":"p","article-title":"Analysis of the immunogenicity of a pox-vector (NYVAC)-based vaccine expressing env, gag, pol and nef proteins of HIV-1 subtype C","volume":"04","author":"Harari","year":"2004","journal-title":"AIDS Vaccine"},{"key":"R39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.76.2.730-742.2002","article-title":"Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1046-2023(03)00139-7","article-title":"Mucosal immunization with DNA vaccines","volume":"31","author":"Hobson","year":"2003","journal-title":"Methods"},{"key":"R41","first-page":"30","article-title":"Oral and nasal immunization with Poxvirus vacciniae. 3","volume-title":"Animal experiments. Zentralbl Bakteriol [Orig B]","volume":"156","author":"Hochstein-Mintzel","year":"1972"},{"key":"R42","first-page":"283","article-title":"An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author's transl","volume-title":"Zentralbl Bakteriol [Orig A]","volume":"230","author":"Hochstein-Mintzel","year":"1975"},{"key":"R43","first-page":"260","article-title":"Oral immunization against smallpox","volume":"33","author":"Hochstein-Mintzel","year":"1976","journal-title":"Dev Biol Stand"},{"key":"R44","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"R45","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0264-410X(03)00206-8","article-title":"Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges","volume":"21","author":"Holmgren","year":"2003","journal-title":"Vaccine"},{"key":"R46","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.133.6.2955","article-title":"The response of gut-associated T lymphocytes to intestinal viral immunization","volume":"133","author":"Issekutz","year":"1984","journal-title":"J Immunol"},{"key":"R47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/JVI.65.2.657-663.1991","article-title":"Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus","volume":"65","author":"Kanesaki","year":"1991","journal-title":"J Virol"},{"key":"R48","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1128\/JVI.72.12.10180-10188.1998","article-title":"Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus","volume":"72","author":"Kent","year":"1998","journal-title":"J Virol"},{"key":"R49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/14760584.3.4.453","article-title":"Antigen delivery systems","volume":"3","author":"Kersten","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"R50","first-page":"137","article-title":"Rabies oral immunization","volume":"146","author":"Koprowski","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"R51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.169.1.566","article-title":"Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle","volume":"169","author":"Kozlowski","year":"2002","journal-title":"J Immunol"},{"key":"R52","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"R53","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1073\/pnas.0409846102","article-title":"Vaccinia viruses with a serpin gene deletion and expressing IFN- \u03b3 induce potent immune responses without detectable replication in vivo","volume":"102","author":"Legrand","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.90.11.5214","article-title":"Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria","volume":"90","author":"Li","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1099\/vir.0.79869-0","article-title":"Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen","volume":"85","author":"Makitalo","year":"2004","journal-title":"J Gen Virol"},{"key":"R56","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4049\/jimmunol.122.5.1892","article-title":"Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues","volume":"122","author":"McDermott","year":"1979","journal-title":"J Immunol"},{"key":"R57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"R58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00916814","article-title":"Regulation of IgA synthesis and immune response by T cells and interleukins","volume":"9","author":"McGhee","year":"1989","journal-title":"J Clin Immunol"},{"key":"R59","first-page":"23","article-title":"Prime-boost immunization strategies for infectious diseases","volume":"4","author":"McShane","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"R60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"J Exp Med"},{"key":"R61","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.91.23.11187","article-title":"Enteric immunization of mice against influenza with recombinant vaccinia","volume":"91","author":"Meitin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R62","doi-asserted-by":"crossref","first-page":"S470","DOI":"10.1086\/314806","article-title":"Mucosal immune system of the human genital tract","volume":"179","author":"Mestecky","year":"1999","journal-title":"J Infect Dis"},{"key":"R63","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety","volume":"93","author":"Moss","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R64","first-page":"2849","article-title":"Poxviridae : the viruses and their replication","volume-title":"In Fields Virology","author":"Moss","year":"2001"},{"key":"R65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/311067a0","article-title":"Live recombinant vaccinia virus protects chimpanzees against hepatitis B","volume":"311","author":"Moss","year":"1984","journal-title":"Nature"},{"key":"R66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-4899-1382-1_2","article-title":"Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates","volume":"397","author":"Moss","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"R67","first-page":"374","article-title":"Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses","volume":"3","author":"Newman","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"R68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"R69","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/S0264-410X(01)00078-0","article-title":"Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene","volume":"19","author":"Okuda","year":"2001","journal-title":"Vaccine"},{"key":"R70","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/514175","article-title":"Development of novel influenza virus vaccines and vectors","volume":"176","author":"Palese","year":"1997","journal-title":"J Infect Dis"},{"key":"R71","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"R72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/0022-1317-70-2-429","article-title":"Use of human adenovirus-based vectors for antigen expression in animals","volume":"70","author":"Prevec","year":"1989","journal-title":"J Gen Virol"},{"key":"R73","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","article-title":"Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration","volume":"148","author":"Ramirez","year":"2003","journal-title":"Arch Virol"},{"key":"R74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/icb.1997.60","article-title":"DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors","volume":"75","author":"Ramsay","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"R75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"R76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"key":"R77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/0022-1317-80-1-217","article-title":"A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine","volume":"80","author":"Rodriguez","year":"1999","journal-title":"J Gen Virol"},{"key":"R78","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","article-title":"Oral immunization and protection of raccoons ( Procyon lotor ) with a vaccinia-rabies glycoprotein recombinant virus vaccine","volume":"83","author":"Rupprecht","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol Rev"},{"key":"R80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0264-410X(01)00321-8","article-title":"Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity","volume":"20","author":"Singh","year":"2001","journal-title":"Vaccine"},{"key":"R81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-2478(98)00125-4","article-title":"Vaccinia virus immune evasion","volume":"65","author":"Smith","year":"1999","journal-title":"Immunol Lett"},{"key":"R82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA","volume":"25","author":"Smith","year":"1983","journal-title":"Gene"},{"key":"R83","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1073\/pnas.80.23.7155","article-title":"Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters","volume":"80","author":"Smith","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1997.tb01012.x","article-title":"Vaccinia virus immune evasion","volume":"159","author":"Smith","year":"1997","journal-title":"Immunol Rev"},{"key":"R85","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.4049\/jimmunol.167.9.5386","article-title":"Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization","volume":"167","author":"Staats","year":"2001","journal-title":"J Immunol"},{"key":"R86","doi-asserted-by":"crossref","first-page":"11659","DOI":"10.1128\/JVI.76.22.11659-11676.2002","article-title":"Both mucosal and systemic routes of immunization with the live, attenuated NYVAC\/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8+ T-cell responses in mucosal tissues of macaques","volume":"76","author":"Stevceva","year":"2002","journal-title":"J Virol"},{"key":"R87","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"key":"R89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"key":"R90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0042-6822(92)90321-F","article-title":"Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins","volume":"187","author":"Taylor","year":"1992","journal-title":"Virology"},{"key":"R91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0264-410X(94)00028-L","article-title":"Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species","volume":"13","author":"Taylor","year":"1995","journal-title":"Vaccine"},{"key":"R92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0105-2896.2004.0147.x","article-title":"Molecular adjuvants for mucosal immunity","volume":"199","author":"Toka","year":"2004","journal-title":"Immunol Rev"},{"key":"R93","first-page":"363","article-title":"Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein","volume":"51","author":"Tolson","year":"1987","journal-title":"Can J Vet Res"},{"key":"R94","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"key":"R95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1566524033479816","article-title":"Live recombinant vectors for AIDS vaccine development","volume":"3","author":"Voltan","year":"2003","journal-title":"Curr Mol Med"},{"key":"R96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.174.1.449","article-title":"Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers","volume":"174","author":"Vuola","year":"2005","journal-title":"J Immunol"},{"key":"R97","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/0889222041725253","article-title":"An SHIV DNA\/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS","volume":"20","author":"Wang","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R98","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0264-410X(98)00211-4","article-title":"Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection","volume":"17","author":"Welter","year":"1999","journal-title":"Vaccine"},{"key":"R99","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0264-410X(01)00480-7","article-title":"Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein","volume":"20","author":"Wierzbicki","year":"2002","journal-title":"Vaccine"},{"key":"R100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"R101","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/382088","article-title":"Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein","volume":"189","author":"Wright","year":"2004","journal-title":"J Infect Dis"},{"key":"R102","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"Wyatt","year":"1996","journal-title":"Vaccine"},{"key":"R103","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0264-410X(99)00257-1","article-title":"Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA","volume":"18","author":"Wyatt","year":"1999","journal-title":"Vaccine"},{"key":"R104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.398","article-title":"New generation of mucosal adjuvants for the induction of protective immunity","volume":"13","author":"Yuki","year":"2003","journal-title":"Rev Med Virol"},{"key":"R105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.2000.0792","article-title":"A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8+ T cells","volume":"280","author":"Zavala","year":"2001","journal-title":"Virology"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81181-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:36:37Z","timestamp":1683254197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81181-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":105,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.81181-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}